1	Human	human	_	_	_	_	_	_	_
2	T-cell	T-cell	_	_	_	_	_	_	_
3	leukemia	leukemia	_	_	_	_	_	_	_
4	virus	virus	_	_	_	_	_	_	_
5	type	type	_	_	_	_	_	_	_
6	1	1	_	_	_	_	_	_	_
7	Tax	tax	_	_	_	_	_	_	_
8	induction	induction	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
11	involves	involve	_	_	_	_	_	_	_
12	activation	activation	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	IkappaB	IkappaB	_	_	_	_	_	_	_
16	kinase	kinase	_	_	_	_	_	_	_
17	alpha	alpha	_	_	_	_	_	_	_
18	(	(	_	_	_	_	_	_	_
19	IKKalpha	IKKalpha	_	_	_	_	_	_	_
20	)	)	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	IKKbeta	IKKbeta	_	_	_	_	_	_	_
23	cellular	cellular	_	_	_	_	_	_	_
24	kinases	kinase	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	Tax	Tax	_	_	_	_	_	_	_
2	corresponds	correspond	_	_	_	_	_	_	_
3	to	to	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	40-kDa	40-kda	_	_	_	_	_	_	_
6	transforming	transform	_	_	_	_	_	_	_
7	protein	protein	_	_	_	_	_	_	_
8	from	from	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	pathogenic	pathogenic	_	_	_	_	_	_	_
11	retrovirus	retrovirus	_	_	_	_	_	_	_
12	human	human	_	_	_	_	_	_	_
13	T-cell	t-cell	_	_	_	_	_	_	_
14	leukemia	leukemia	_	_	_	_	_	_	_
15	virus	virus	_	_	_	_	_	_	_
16	type	type	_	_	_	_	_	_	_
17	1	1	_	_	_	_	_	_	_
18	(	(	_	_	_	_	_	_	_
19	HTLV-1	HTLV-1	_	_	_	_	_	_	_
20	)	)	_	_	_	_	_	_	_
21	that	that	_	_	_	_	_	_	_
22	activates	activate	_	_	_	_	_	_	_
23	nuclear	nuclear	_	_	_	_	_	_	_
24	expression	expression	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	NF-kappaB/Rel	NF-kappaB/Rel	_	_	_	_	_	_	_
28	family	family	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	transcription	transcription	_	_	_	_	_	_	_
31	factors	factor	_	_	_	_	_	_	_
32	by	by	_	_	_	_	_	_	_
33	an	an	_	_	_	_	_	_	_
34	unknown	unknown	_	_	_	_	_	_	_
35	mechanism	mechanism	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	Tax	Tax	_	_	_	_	_	_	_
2	expression	expression	_	_	_	_	_	_	_
3	promotes	promote	_	_	_	_	_	_	_
4	N-terminal	n-terminal	_	_	_	_	_	_	_
5	phosphorylation	phosphorylation	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	degradation	degradation	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	IkappaB	IkappaB	_	_	_	_	_	_	_
10	alpha	alpha	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	principal	principal	_	_	_	_	_	_	_
14	cytoplasmic	cytoplasmic	_	_	_	_	_	_	_
15	inhibitor	inhibitor	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	studies	study	_	_	_	_	_	_	_
3	now	now	_	_	_	_	_	_	_
4	demonstrate	demonstrate	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	HTLV-1	HTLV-1	_	_	_	_	_	_	_
7	Tax	Tax	_	_	_	_	_	_	_
8	activates	activate	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	recently	recently	_	_	_	_	_	_	_
11	identified	identify	_	_	_	_	_	_	_
12	cellular	cellular	_	_	_	_	_	_	_
13	kinases	kinase	_	_	_	_	_	_	_
14	IkappaB	IkappaB	_	_	_	_	_	_	_
15	kinase	kinase	_	_	_	_	_	_	_
16	alpha	alpha	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	IKKalpha	IKKalpha	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	IKKbeta	IKKbeta	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	which	which	_	_	_	_	_	_	_
24	normally	normally	_	_	_	_	_	_	_
25	phosphorylate	phosphorylate	_	_	_	_	_	_	_
26	IkappaB	IkappaB	_	_	_	_	_	_	_
27	alpha	alpha	_	_	_	_	_	_	_
28	on	on	_	_	_	_	_	_	_
29	both	both	_	_	_	_	_	_	_
30	of	of	_	_	_	_	_	_	_
31	its	its	_	_	_	_	_	_	_
32	N-terminal	n-terminal	_	_	_	_	_	_	_
33	regulatory	regulatory	_	_	_	_	_	_	_
34	serines	serine	_	_	_	_	_	_	_
35	in	in	_	_	_	_	_	_	_
36	response	response	_	_	_	_	_	_	_
37	to	to	_	_	_	_	_	_	_
38	tumor	tumor	_	_	_	_	_	_	_
39	necrosis	necrosis	_	_	_	_	_	_	_
40	factor	factor	_	_	_	_	_	_	_
41	alpha	alpha	_	_	_	_	_	_	_
42	(	(	_	_	_	_	_	_	_
43	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
44	)	)	_	_	_	_	_	_	_
45	and	and	_	_	_	_	_	_	_
46	interleukin-1	interleukin-1	_	_	_	_	_	_	_
47	(	(	_	_	_	_	_	_	_
48	IL-1	il-1	_	_	_	_	_	_	_
49	)	)	_	_	_	_	_	_	_
50	stimulation	stimulation	_	_	_	_	_	_	_
51	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	mutant	mutant	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	Tax	Tax	_	_	_	_	_	_	_
8	termed	term	_	_	_	_	_	_	_
9	M22	m22	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	which	which	_	_	_	_	_	_	_
12	does	do	_	_	_	_	_	_	_
13	not	not	_	_	_	_	_	_	_
14	induce	induce	_	_	_	_	_	_	_
15	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	fails	fail	_	_	_	_	_	_	_
18	to	to	_	_	_	_	_	_	_
19	activate	activate	_	_	_	_	_	_	_
20	either	either	_	_	_	_	_	_	_
21	IKKalpha	IKKalpha	_	_	_	_	_	_	_
22	or	or	_	_	_	_	_	_	_
23	IKKbeta	IKKbeta	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	endogenous	endogenous	_	_	_	_	_	_	_
4	IKK	IKK	_	_	_	_	_	_	_
5	enzymatic	enzymatic	_	_	_	_	_	_	_
6	activity	activity	_	_	_	_	_	_	_
7	was	be	_	_	_	_	_	_	_
8	significantly	significantly	_	_	_	_	_	_	_
9	elevated	elevated	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	HTLV-1-infected	htlv-1-infected	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	Tax-expressing	tax-expressing	_	_	_	_	_	_	_
14	T-cell	t-cell	_	_	_	_	_	_	_
15	lines	line	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	Transfection	transfection	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	kinase-deficient	kinase-deficient	_	_	_	_	_	_	_
4	mutants	mutant	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	IKKalpha	IKKalpha	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	IKKbeta	IKKbeta	_	_	_	_	_	_	_
9	into	into	_	_	_	_	_	_	_
10	either	either	_	_	_	_	_	_	_
11	human	human	_	_	_	_	_	_	_
12	Jurkat	Jurkat	_	_	_	_	_	_	_
13	T	t	_	_	_	_	_	_	_
14	or	or	_	_	_	_	_	_	_
15	293	293	_	_	_	_	_	_	_
16	cells	cell	_	_	_	_	_	_	_
17	also	also	_	_	_	_	_	_	_
18	inhibits	inhibit	_	_	_	_	_	_	_
19	NF-kappaB-dependent	nf-kappab-dependent	_	_	_	_	_	_	_
20	reporter	reporter	_	_	_	_	_	_	_
21	gene	gene	_	_	_	_	_	_	_
22	expression	expression	_	_	_	_	_	_	_
23	induced	induce	_	_	_	_	_	_	_
24	by	by	_	_	_	_	_	_	_
25	Tax	Tax	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Similarly	similarly	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	kinase-deficient	kinase-deficient	_	_	_	_	_	_	_
5	mutant	mutant	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	NIK	NIK	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	NF-kappaB-inducing	NF-kappaB-inducing	_	_	_	_	_	_	_
10	kinase	kinase	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	which	which	_	_	_	_	_	_	_
14	represents	represent	_	_	_	_	_	_	_
15	an	an	_	_	_	_	_	_	_
16	upstream	upstream	_	_	_	_	_	_	_
17	kinase	kinase	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	IL-1	il-1	_	_	_	_	_	_	_
23	signaling	signaling	_	_	_	_	_	_	_
24	pathways	pathway	_	_	_	_	_	_	_
25	leading	lead	_	_	_	_	_	_	_
26	to	to	_	_	_	_	_	_	_
27	IKKalpha	IKKalpha	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	IKKbeta	IKKbeta	_	_	_	_	_	_	_
30	activation	activation	_	_	_	_	_	_	_
31	,	,	_	_	_	_	_	_	_
32	blocks	block	_	_	_	_	_	_	_
33	Tax	Tax	_	_	_	_	_	_	_
34	induction	induction	_	_	_	_	_	_	_
35	of	of	_	_	_	_	_	_	_
36	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	plasma	plasma	_	_	_	_	_	_	_
4	membrane-proximal	membrane-proximal	_	_	_	_	_	_	_
5	elements	element	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	these	these	_	_	_	_	_	_	_
8	proinflammatory	proinflammatory	_	_	_	_	_	_	_
9	cytokine	cytokine	_	_	_	_	_	_	_
10	pathways	pathway	_	_	_	_	_	_	_
11	are	be	_	_	_	_	_	_	_
12	apparently	apparently	_	_	_	_	_	_	_
13	not	not	_	_	_	_	_	_	_
14	involved	involve	_	_	_	_	_	_	_
15	since	since	_	_	_	_	_	_	_
16	dominant	dominant	_	_	_	_	_	_	_
17	negative	negative	_	_	_	_	_	_	_
18	mutants	mutant	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	TRAF2	traf2	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	TRAF6	traf6	_	_	_	_	_	_	_
24	adaptors	adaptor	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	which	which	_	_	_	_	_	_	_
27	effectively	effectively	_	_	_	_	_	_	_
28	block	block	_	_	_	_	_	_	_
29	signaling	signal	_	_	_	_	_	_	_
30	through	through	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	cytoplasmic	cytoplasmic	_	_	_	_	_	_	_
33	tails	tail	_	_	_	_	_	_	_
34	of	of	_	_	_	_	_	_	_
35	the	the	_	_	_	_	_	_	_
36	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
37	and	and	_	_	_	_	_	_	_
38	IL-1	il-1	_	_	_	_	_	_	_
39	receptors	receptor	_	_	_	_	_	_	_
40	,	,	_	_	_	_	_	_	_
41	respectively	respectively	_	_	_	_	_	_	_
42	,	,	_	_	_	_	_	_	_
43	do	do	_	_	_	_	_	_	_
44	not	not	_	_	_	_	_	_	_
45	inhibit	inhibit	_	_	_	_	_	_	_
46	Tax	Tax	_	_	_	_	_	_	_
47	induction	induction	_	_	_	_	_	_	_
48	of	of	_	_	_	_	_	_	_
49	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
50	.	.	_	_	_	_	_	_	_

1	Together	together	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	these	these	_	_	_	_	_	_	_
4	studies	study	_	_	_	_	_	_	_
5	demonstrate	demonstrate	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	HTLV-1	HTLV-1	_	_	_	_	_	_	_
8	Tax	Tax	_	_	_	_	_	_	_
9	exploits	exploit	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	distal	distal	_	_	_	_	_	_	_
12	part	part	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	proinflammatory	proinflammatory	_	_	_	_	_	_	_
16	cytokine	cytokine	_	_	_	_	_	_	_
17	signaling	signaling	_	_	_	_	_	_	_
18	cascade	cascade	_	_	_	_	_	_	_
19	leading	lead	_	_	_	_	_	_	_
20	to	to	_	_	_	_	_	_	_
21	induction	induction	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	pathological	pathological	_	_	_	_	_	_	_
3	alteration	alteration	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	this	this	_	_	_	_	_	_	_
6	cytokine	cytokine	_	_	_	_	_	_	_
7	pathway	pathway	_	_	_	_	_	_	_
8	leading	lead	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
11	activation	activation	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	Tax	Tax	_	_	_	_	_	_	_
14	may	may	_	_	_	_	_	_	_
15	play	play	_	_	_	_	_	_	_
16	a	a	_	_	_	_	_	_	_
17	central	central	_	_	_	_	_	_	_
18	role	role	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	HTLV-1-mediated	htlv-1-mediated	_	_	_	_	_	_	_
21	transformation	transformation	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	human	human	_	_	_	_	_	_	_
24	T	t	_	_	_	_	_	_	_
25	cells	cell	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	clinically	clinically	_	_	_	_	_	_	_
28	manifested	manifest	_	_	_	_	_	_	_
29	as	as	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	adult	adult	_	_	_	_	_	_	_
32	T-cell	t-cell	_	_	_	_	_	_	_
33	leukemia	leukemia	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

